Comparison of Guidelines for Diagnosis and Treatment of Primary Liver Cancer(2024 Edition)with KLCA-NCC Guidelines(2022 Edition)and JSH Guidelines(2021 Edition)in Imaging Diagnosis:Integrating Strengths and Embracing Inclusivity
10.3969/j.issn.1005-5185.2024.07.001
- VernacularTitle:《原发性肝癌诊疗指南(2024年版)》与KLCA-NCC指南(2022年版)和JSH指南(2021年版)影像诊断比较:博采众长,兼容并蓄
- Author:
Junjie SHU
1
;
Jiacheng ZHANG
;
Lan ZHANG
;
Wentao WANG
;
Shengxiang RAO
Author Information
1. 河南中医药大学第一附属医院MRI科,河南 郑州 450000
- Keywords:
Carcinoma,hepatocellular;
Magnetic resonance imaging;
Tomography,X-ray computed;
Ultrasonography;
JSH guidelines;
KLCA-NCC guidelines;
Diagnosis;
Staging;
Screening;
Interpretation
- From:
Chinese Journal of Medical Imaging
2024;32(7):641-646
- CountryChina
- Language:Chinese
-
Abstract:
The incidence and mortality rates of primary liver cancer remain very high,posing a serious threat to the global public health.In Asia,the guidelines from the Korean Liver Cancer Association-National Cancer Center,the Japan Society of Hepatology,and the Chinese Guidelines for Diagnosis and Treatment of Primary Liver Cancer(2024 edition)have significant influence and provide important guidance for the diagnosis and treatment of primary liver cancer.These guidelines,based on their own national condition,background,evidence and clinical practice,exhibit both commonalities and divergences in the imaging diagnosis of liver cancer.This study aims to provide a more comprehensive and scientific reference for clinicians by comparing the specific contents of three guidelines regarding screening,surveillance,imaging diagnosis and staging of liver cancer,thereby promoting the standardized diagnosis and treatment of clinical practice in the primary liver cancer.
